Kaposi sarcoma inflammatory cytokine syndrome (KICS): A rare but potentially treatable condition

Michael Karass*, Emily Grossniklaus, Talal Seoud, Sanjay Jain, Daniel A. Goldstein

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Kaposi sarcoma inflammatory cytokine syndrome (KICS) is a newly-described condition affecting individuals who are HIV-positive and are infected with human herpesvirus 8 (HHV-8). This is a syndrome that in some ways mimics severe sepsis with associated acute respiratory distress syndrome, possibly requiring a ventilator and vasopressor support. However, unlike severe sepsis, antibiotics provide no benefit. Management of KICS has not been fully elucidated because of its high mortality rate. However, the syndrome has been successfully treated in some cases with immunomodulatory therapy. It is crucial for oncologists to be able to recognize this syndrome and to institute the appropriate therapy.

Original languageEnglish
Pages (from-to)623-625
Number of pages3
JournalOncologist
Volume22
Issue number5
DOIs
StatePublished - May 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Kaposi sarcoma inflammatory cytokine syndrome (KICS): A rare but potentially treatable condition'. Together they form a unique fingerprint.

Cite this